Spiriva Study – Possible Risk of Heart Attacks

The blockbuster inhaled lung medication Spiriva , marketed by Pfizer Inc and Boehringer Ingelheim, raises the risk of heart attack, stroke and death from heart disease, researchers said on Tuesday.

People who took Spiriva or Boehringer’s older medication, Atrovent, for at least a month were 58 percent more likely to experience heart attack, stroke or cardiovascular death than those taking other drugs, the U.S. researchers wrote in the Journal of the American Medical Association.

Germany’s privately held Boehringer Ingelheim and Pfizer said they strongly disagreed with the study’s conclusions.

Via -(Reuters)